Bioray Pharmaceutical Co., Ltd.

This study tests whether a new drug called HS627 works as well as the approved drug pertuzumab when both are given with standard chemotherapy before surgery for early-stage or locally advanced HER2-positive breast cancer. About 408 participants will receive either HS627 or pertuz…

This early-stage study tests a new drug, BR115, in 120 people with advanced solid tumors that have not responded to other treatments. The main goal is to check the drug's safety and how the body processes it. Participants receive the drug weekly after an initial two doses in the …

This study tests a new medicine, zuberitamab, against a standard treatment (cyclosporine) in 135 adults with primary membranous nephropathy, a kidney condition that causes protein leakage. The goal is to see if zuberitamab can better reduce protein in urine over 76 weeks, while c…